ALUR
ALLURION TECHNOLOGIES, INC.
NYSE · Healthcare · Medical - Devices · US
$1.05
−11.76%Next report
Analyst consensus
- Next report date
- Nov 18, 2026
- EPS estimate
- -$4.80
- Revenue estimate
- $3.6M
Latest reported
- Last report date
- May 27, 2026
- EPS actual
- -$0.46
- EPS estimate
- -$0.34
- Revenue actual
- $2.9M
- Revenue estimate
- $3.1M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 2
- EPS misses (12Q)
- 4
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- +4.5%
- Revenue beats (12Q)
- 2
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| May 27, 2026 | -$0.34 | -$0.46 | Miss -35.29% | $2.9M |
| Nov 12, 2025 | -$0.63 | -$1.18 | Miss -87.30% | $2.7M |
| Aug 19, 2025 | -$0.65 | -$0.57 | Beat 12.31% | $3.4M |
| May 14, 2025 | -$1.53 | $0.43 | Beat 128.10% | $5.6M |
| Mar 26, 2025 | -$5.00 | -$7.00 | Miss -40.00% | $5.6M |
| Mar 21, 2024 | -$13 | -$16 | Miss -23.53% | $8.2M |
| Nov 13, 2023 | — | -$15 | — | $18.2M |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 18, 2026